Login
$MESO
$12.67 +$0.22 (1.77%) After hours

Company Executives

Officer Source
Silviu Itescu Also a director
Chief Executive Officer (CEO)
Eric Rose Also a director
Chief Medical Officer (CMO)
Marcelo Santoro
Chief Commercial Officer
Paul Simmons
Scientific Advisor to the Chief Executive Officer
Paul Hughes
Joint Company Secretary
Niva Sivakumar
Joint Company Secretary
Justin Horst
Head of Manufacturing
Fiona See
Head of Translational Research
Geraldine Storton
Head of Regulatory Affairs and Quality Management

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 20-F annual report

Directors
8
serving now
Average tenure
17.0 years
from year joined
CEO also chairs the board
No
Philip Facchina
Director On board Committees Pay Source
Philip Facchina
Not stated
Nomination and Remuneration Committee Audit and Risk Committee
Not stated
Silviu Itescu
2004
22 years
Clinical Committee
Paid as CEO
Eric Rose
Not stated
Clinical Committee
Not stated
Jane Bell
Not stated
Nomination and Remuneration Committee · Chair Audit and Risk Committee
Not stated
William Burns
2014
12 years
Nomination and Remuneration Committee · Chair Clinical Committee
Not stated
Lyn Cobley
Not stated
Audit and Risk Committee · Chair Nomination and Remuneration Committee
Not stated
Gregory George
Not stated
Clinical Committee · Chair
Not stated
Philip Krause
Not stated
Clinical Committee
Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. MESOBLAST LTD has not filed one with the SEC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support